Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Recruiting
Phase 1
Phase 2
Interventional Study
Huntington Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 21 (estimated)
- Sponsor
- Leslie Thompson · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Please note this may not be a complete list of eligibility criteria.
Inclusion Criteria:
* Have decision-making capacity and be able to provide written informed consent.
* Are between 18 to 65 years of age
* Have genetically confirmed diagnosis of Huntington's Disease
* Able to undergo MRI scans, …
Contacts